Research Article: Enhancing Dendritic Cell Activation Through Manganese-Coated Nanovaccine Targeting the cGAS-STING Pathway
Abstract:
Nanovaccines represent a promising advancement in the field of vaccination, which uses nanoparticles as carriers and adjuvants to enhance antigen delivery and presentation within the immune system. Among the key players in this process, DCs play a critical role as primary antigen-presenting cells (APCs), initiating and orchestrating adaptive immune responses through antigen capture, processing, and presentation to T cells. The effective activation of DCs by nanovaccines is essential for the induction of potent and protective immune responses against diverse pathogens and tumors., However, current nanovaccine strategies encounter challenges related to DC activation, including limited uptake efficiency, rapid clearance, and intracellular degradation of antigens, resulting in suboptimal antigen cross-presentation and attenuated immune signaling.
Introduction:
Nanovaccines represent a promising advancement in the field of vaccination, which uses nanoparticles as carriers and adjuvants to enhance antigen delivery and presentation within the immune system. Among the key players in this process, DCs play a critical role as primary antigen-presenting cells (APCs), initiating and orchestrating adaptive immune responses through antigen capture, processing, and presentation to T cells. The effective activation of DCs by nanovaccines is essential for the induction of potent and…
Read more